|
1
|
Nishida N, Yano H, Nishida T, Kamura T and
Kojiro M: Angiogenesis in cancer. Vasc Health Risk Manag.
2:213–219. 2006. View Article : Google Scholar
|
|
2
|
Uzzan B, Nicolas P, Cucherat M and Perret
GY: Microvessel density as a prognostic factor in women with breast
cancer: a systematic review of the literature and meta-analysis.
Cancer Res. 64:2941–2955. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bremnes RM, Camps C and Sirera R:
Angiogenesis in non-small cell lung cancer: the prognostic impact
of neoangiogenesis and the cytokines VEGF and bFGF in tumours and
blood. Lung Cancer. 51:143–158. 2006. View Article : Google Scholar
|
|
4
|
Zhao HC, Qin R, Chen XX, et al:
Microvessel density is a prognostic marker of human gastric cancer.
World J Gastroenterol. 12:7598–7603. 2006.PubMed/NCBI
|
|
5
|
Vaupel P: The role of hypoxia-induced
factors in tumor progression. Oncologist. 9(Suppl 5): S10–S17.
2004. View Article : Google Scholar
|
|
6
|
Fang L, Choi SH, Baek JS, et al: Control
of angiogenesis by AIBP-mediated cholesterol efflux. Nature.
498:118–122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang CY, Liu PY and Liao JK: Pleiotropic
effects of statin therapy: molecular mechanisms and clinical
results. Trends Mol Med. 14:37–44. 2008. View Article : Google Scholar
|
|
8
|
Grosser N, Hemmerle A, Berndt G, et al:
The antioxidant defense protein heme oxygenase 1 is a novel target
for statins in endothelial cells. Free Radic Biol Med.
37:2064–2071. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Newton CJ, Ran G, Xie YX, et al:
Statin-induced apoptosis of vascular endothelial cells is blocked
by dexamethasone. J Endocrinol. 174:7–16. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Asakage M, Tsuno NH, Kitayama J, et al:
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor
(pravastatin) inhibits endothelial cell proliferation dependent on
G1 cell cycle arrest. Anticancer Drugs. 15:625–632. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Weis M, Heeschen C, Glassford AJ and Cooke
JP: Statins have biphasic effects on angiogenesis. Circulation.
105:739–745. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gross A, McDonnell JM and Korsmeyer SJ:
BCL-2 family members and the mitochondria in apoptosis. Genes Dev.
13:1899–1911. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hoeben A, Landuyt B, Highley MS, Wildiers
H, Van Oosterom AT and De Bruijn EA: Vascular endothelial growth
factor and angiogenesis. Pharmacol Rev. 56:549–580. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Polet F and Feron O: Endothelial cell
metabolism and tumour angiogenesis: glucose and glutamine as
essential fuels and lactate as the driving force. J Intern Med.
273:156–165. 2013. View Article : Google Scholar
|
|
15
|
Wise DR, Ward PS, Shay JE, et al: Hypoxia
promotes isocitrate dehydrogenase-dependent carboxylation of
alpha-ketoglutarate to citrate to support cell growth and
viability. Proc Natl Acad Sci USA. 108:19611–19616. 2011.
View Article : Google Scholar
|
|
16
|
Manalo DJ, Rowan A, Lavoie T, et al:
Transcriptional regulation of vascular endothelial cell responses
to hypoxia by HIF-1. Blood. 105:659–669. 2005. View Article : Google Scholar
|
|
17
|
Humar R, Kiefer FN, Berns H, Resink TJ and
Battegay EJ: Hypoxia enhances vascular cell proliferation and
angiogenesis in vitro via rapamycin (mTOR)-dependent signaling.
FASEB J. 16:771–780. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Osende JI, Ruiz-Ortega M, Blanco-Colio LM
and Egido J: Statins to prevent cardiovascular events in
hypertensive patients. The ASCOT-LLA study. Nephrol Dial
Transplant. 19:528–531. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pande A, Lombardo J, Spangenthal E and
Javle M: Hypertension secondary to anti-angiogenic therapy:
experience with bevacizumab. Anticancer Res. 27:3465–3470.
2007.PubMed/NCBI
|
|
20
|
Osmak M: Statins and cancer: current and
future prospects. Cancer Lett. 324:1–12. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lavie O, Pinchev M, Rennert HS, Segev Y
and Rennert G: The effect of statins on risk and survival of
gynecological malignancies. Gynecol Oncol. 130:615–619. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cardwell CR, Hicks BM, Hughes C and Murray
LJ: Statin use after colorectal cancer diagnosis and survival: a
population-based cohort study. J Clin Oncol. 32:3177–3183. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schaefer CA, Kuhlmann CR, Weiterer S, et
al: Statins inhibit hypoxia-induced endothelial proliferation by
preventing calcium-induced ROS formation. Atherosclerosis.
185:290–296. 2006. View Article : Google Scholar
|
|
24
|
Deichmann R, Lavie C and Andrews S:
Coenzyme q10 and statin-induced mitochondrial dysfunction. Ochsner
J. 10:16–21. 2010.
|
|
25
|
Liu Y, Samuel BS, Breen PC and Ruvkun G:
Caenorhabditis elegans pathways that surveil and defend
mitochondria. Nature. 508:406–410. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Satoh M, Fujimoto S, Horike H, et al:
Mitochondrial damage-induced impairment of angiogenesis in the
aging rat kidney. Lab Invest. 91:190–202. 2011. View Article : Google Scholar
|
|
27
|
Loboda A, Jazwa A, Jozkowicz A, Molema G
and Dulak J: Angiogenic transcriptome of human microvascular
endothelial cells: effect of hypoxia, modulation by atorvastatin.
Vascul Pharmacol. 44:206–214. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Crosbie J, Magnussen M, Dornbier R,
Iannone A and Steele TA: Statins inhibit proliferation and
cytotoxicity of a human leukemic natural killer cell line. Biomark
Res. 1:332013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kuo YS, Tang YB, Lu TY, Wu HC and Lin CT:
IGFBP-6 plays a role as an oncosuppressor gene in NPC pathogenesis
through regulating EGR-1 expression. J Pathol. 222:299–309. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Raykha C, Crawford J, Gan BS, Fu P, Bach
LA and O’Gorman DB: IGF-II and IGFBP-6 regulate cellular
contractility and proliferation in Dupuytren’s disease. Biochim
Biophys Acta. 1832:1511–1519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Grellier P, De Galle B and Babajko S:
Expression of insulin-like growth factor-binding protein 6
complementary DNA alters neuroblastoma cell growth. Cancer Res.
58:1670–1676. 1998.PubMed/NCBI
|
|
32
|
DiPaola RS: To arrest or not to
G2-M Cell-cycle arrest: commentary re: A.K. Tyagi, et
al: Silibinin strongly synergizes human prostate carcinoma DU145
cells to doxorubicin-induced growth inhibition, G2-M
arrest, and apoptosis. Clin Cancer Res 8: 3512–3519, 2002. Clin
Cancer Res. 8:3311–3314. 2002.PubMed/NCBI
|
|
33
|
Toyoshima H and Hunter T: p27, a novel
inhibitor of G1 cyclin-Cdk protein kinase activity, is related to
p21. Cell. 78:67–74. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yin Y, Tainsky MA, Bischoff FZ, Strong LC
and Wahl GM: Wild-type p53 restores cell cycle control and inhibits
gene amplification in cells with mutant p53 alleles. Cell.
70:937–948. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Basu A and Haldar S: The relationship
between BcI2, Bax and p53: consequences for cell cycle progression
and cell death. Mol Hum Reprod. 4:1099–1109. 1998. View Article : Google Scholar
|
|
36
|
Sarela AI, Verbeke CS, Ramsdale J, Davies
CL, Markham AF and Guillou PJ: Expression of survivin, a novel
inhibitor of apoptosis and cell cycle regulatory protein, in
pancreatic adenocarcinoma. Br J Cancer. 86:886–892. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou M, Gu L, Li F, Zhu Y, Woods WG and
Findley HW: DNA damage induces a novel p53-survivin signaling
pathway regulating cell cycle and apoptosis in acute lymphoblastic
leukemia cells. J Pharmacol Exp Ther. 303:124–131. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Maslov S and Sneppen K: Protein
interaction networks beyond artifacts. FEBS Lett. 530:255–256.
2002. View Article : Google Scholar : PubMed/NCBI
|
